Minimizing contrast agent dose during intraarterial gadolinium-enhanced MR angiography: in vitro assessment

J Magn Reson Imaging. 2002 Jan;15(1):55-61. doi: 10.1002/jmri.10027.

Abstract

Purpose: To minimize contrast agent dosage for intra-arterial (IA) contrast-enhanced magnetic resonance angiography (CE-MRA) by examining the effects of encoding order (elliptical vs. sequential) and injection duration (100% to 30% of the acquisition time).

Materials and methods: Catheter-based IA gadolinium (Gd) injections were performed in an arterial flow phantom. Blood flow rates, injection rates, and injection durations were systematically varied. Signal-to-noise (SNR) measurements were obtained in the aorta, renal artery, and common iliac artery.

Results: No significant SNR losses were observed for any of the vessels with 75% injection duration, or for the aorta and iliac artery with 50% injection duration. Excellent images of all vessels were obtained at 50% injection duration. There was no significant SNR difference between encoding schemes.

Conclusion: Contrast agent dosage can be substantially reduced without loss of SNR by limiting injection to part of the imaging acquisition time.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aorta, Abdominal
  • Blood Flow Velocity
  • Contrast Media / administration & dosage*
  • Contrast Media / pharmacokinetics
  • Gadolinium DTPA / administration & dosage*
  • Gadolinium DTPA / pharmacokinetics
  • Iliac Artery
  • Injections, Intra-Arterial
  • Magnetic Resonance Angiography / methods*
  • Phantoms, Imaging
  • Renal Artery

Substances

  • Contrast Media
  • Gadolinium DTPA